HCPCS C2634: Iodine-125 High-Activity Brachytherapy Source
HCPCS Level II code C2634 designates a high-activity, non-stranded iodine-125 brachytherapy source (greater than 1.01 mCi, NIST) billed per source. Brachytherapy sources like these are central to targeted radiation oncology treatments for certain cancers, offering highly localized dosing that can reduce exposure to surrounding healthy tissue. Nationally, accurate coding for these devices affects facility billing, device reimbursement, and tracking of high-cost implantable oncology supplies.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for C2634, how the code is used in procedural billing lines, and typical sites of service where these sources are supplied and implanted. The publication summarizes benchmark considerations, common billing modifiers used with HCPCS Level II codes, and policy updates that commonly influence coverage and payment for radioactive brachytherapy sources.
This resource is aimed at billing professionals, radiation oncology administrators, and policy analysts seeking a national-level briefing on coding, clinical use, and payer considerations related to HCPCS Level II code C2634.
Customize your policy alerts
Sign up for hcpcs C2634 policy alerts
Get alerted when payer policies referencing C2634 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code C2634 describes a brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mCi (NIST), per source. This item represents an individual sealed radioactive source used in brachytherapy procedures where iodine-125 seeds are implanted temporarily or permanently to deliver localized radiation.
Service Type: Brachytherapy radioactive source supply and implant
Typical Site of Service: Hospital outpatient departments, ambulatory surgery centers, and radiation oncology clinics
Data not available in the input.